{
    "clinical_study": {
        "@rank": "164744", 
        "acronym": "PNCA", 
        "arm_group": [
            {
                "arm_group_label": "Parent/Nurse Controlled Analgesia", 
                "arm_group_type": "Active Comparator", 
                "description": "Parent/Nurse Controlled Analgesia will be the method of morphine delivery."
            }, 
            {
                "arm_group_label": "Continuous Opioid Infusion", 
                "arm_group_type": "Active Comparator", 
                "description": "Continuous Opioid Infusion will be the method used to deliver morphine to group 2"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to examine the safety and effectiveness of 2 morphine delivery\n      systems for post-surgical neonates. The investigators hypothesize that this study will be\n      feasible to conduct, and that neonates receiving morphine via a Parent/Nurse Controlled\n      Analgesia pump will receive less morphine and experience fewer side effects than neonates\n      receiving morphine via continuous opioid infusion."
        }, 
        "brief_title": "Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Abdominal Surgery", 
            "Thoracic Surgery"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Surgery Location:\n\n               -  Abdominal or Thoracic\n\n               -  First surgery only\n\n        Age:\n\n          -  Born \u2265 34-44 weeks post-menstrual age\n\n          -  Weight:  Weight at birth or current weight \u22652 kg Intubated or extubated\n\n        Prior opioid exposure:\n\n          -  < 2 days of continuous exposure\n\n          -  if history of > 2 day continuous exposure, must be off continuous drip for a week\n\n          -  Intermittent exposure \u2264 2 days prior to surgery Neonates exposed to chronic opioids\n             in utero *In utero exposure to Selective Seretonin Reuptake Inhibitors and illicit\n             drugs will be screened for and annotated.\n\n        At least 1 parent is English-speaking\n\n        Exclusion Criteria:\n\n          -  Surgery Type:\n\n               -  Cardiac, Patent Ductus Arteriosus Ligation; Omphalocele (if intubated\n                  pre-operatively)\n\n        Diagnoses:\n\n        \u2022 Necrotizing Enterocolitis; Diaphragmatic hernia (unless thoracoscopically repaired);\n        Chemically or physiologically paralyzed Receiving vasopressors Receiving acetaminophen or\n        a benzodiazepine (lorazepam or midazolam) \u2264 24 h before surgery Patients with any of the\n        following:  Epidural; Oscillating ventilator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823497", 
            "org_study_id": "FP4155"
        }, 
        "intervention": {
            "arm_group_label": [
                "Parent/Nurse Controlled Analgesia", 
                "Continuous Opioid Infusion"
            ], 
            "description": "Morphine will be used to control pain post-surgery.", 
            "intervention_name": "Morphine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Morphine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Neonatal Intensive Care Unit", 
            "neonate", 
            "pain", 
            "morphine", 
            "Parent/Nurse Controlled Analgesia"
        ], 
        "lastchanged_date": "January 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Milwaukee", 
                    "country": "United States", 
                    "state": "Wisconsin", 
                    "zip": "53201"
                }, 
                "name": "Children's Hospital of Wisconsin"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Parent/Nurse Controlled Analgesia for Post-Operative Pain Management in Neonates: A Preliminary Randomized Controlled Trial", 
        "other_outcome": {
            "description": "Methadone will serve as a surrogate for tolerance and will be monitored up to 3 days after the morphine has been discontinued.", 
            "measure": "methadone use", 
            "safety_issue": "Yes", 
            "time_frame": "up to 3 days after morphine is discontinued"
        }, 
        "overall_contact": {
            "email": "djirovec@mcw.edu", 
            "last_name": "Derek Jirovec, B.S.", 
            "phone": "414-266-7264"
        }, 
        "overall_contact_backup": {
            "email": "khainswo@mcw.edu", 
            "last_name": "Keri R. Hainsworth, PhD", 
            "phone": "414-266-6306"
        }, 
        "overall_official": [
            {
                "affiliation": "Medical College of Wisconsin", 
                "last_name": "Keri R Hainsworth, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Children's Hospital and Health System  Foundation, Wisconsin", 
                "last_name": "Michelle L Czarnecki, MSN RN-BC CPNP", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The investigators will measure amount of morphine consumed post-surgery in mcg/kg/hour", 
            "measure": "Morphine Consumption", 
            "safety_issue": "No", 
            "time_frame": "5 days post surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823497"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The investigators will assess pain up to 3x per hour for 3 days post-surgery. Good pain control will be defined as pain less than 4 on a 0-10 scale.", 
            "measure": "Pain Control", 
            "safety_issue": "No", 
            "time_frame": "5 days post surgery"
        }, 
        "source": "Medical College of Wisconsin", 
        "sponsors": {
            "collaborator": {
                "agency": "Children's Hospital and Health System  Foundation, Wisconsin", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Medical College of Wisconsin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}